Dori L Klemanski1, Kristine K Browning2,3, Jennifer Kue3. 1. The Ohio State University Comprehensive Cancer Center, James Cancer Hospital, 460 W. 12th Avenue, Columbus, OH, 43210, USA. Dori.Klemanski@osumc.edu. 2. The Ohio State University Comprehensive Cancer Center, James Cancer Hospital, 460 W. 12th Avenue, Columbus, OH, 43210, USA. 3. The Ohio State University College of Nursing, 1585 Neil Avenue, Columbus, OH, 43210, USA.
Abstract
PURPOSE: The purpose of this systematic review was to describe and examine the current use of treatment summaries and survivorship care plans (TSs/SCPs) for cancer survivors, as well as to summarize and critically assess relevant literature regarding their preferences and usefulness. There is a knowledge gap regarding the preferences of stakeholders as to what is useful on a treatment summary or survivorship care plan. METHODS: A systematic review of eligible manuscripts was conducted using preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Relevant studies were identified via PubMed, CINAHL Plus, and the Cochrane Library from 2005 through 2013. Eligible studies were critically appraised with qualitative and quantitative appraisal tools. RESULTS: There were 29 studies included in this review; 19 were quantitative. Survivors and primary care physicians preferred a printable format delivered 0 to 6 months posttreatment and highlighting signs and symptoms of recurrence, late, and long-term effects, and recommendations for healthy living. Oncology providers supported the concept of treatment summary and survivorship care plan but reported significant barriers to their provision. No studies incorporated caregiver perspectives of treatment summary and survivorship care plan. CONCLUSION: This systematic review did not reveal conclusive evidence regarding the needs of survivors or providers regarding treatment summaries and survivorship care plans. A lack of rigorous studies contributed to this. IMPLICATIONS FOR CANCER SURVIVORS: Treatment summaries and survivorship care plans are useful for cancer survivors; however, future rigorous studies should be conducted to identify and prioritize the preferences of survivors regarding these.
PURPOSE: The purpose of this systematic review was to describe and examine the current use of treatment summaries and survivorship care plans (TSs/SCPs) for cancer survivors, as well as to summarize and critically assess relevant literature regarding their preferences and usefulness. There is a knowledge gap regarding the preferences of stakeholders as to what is useful on a treatment summary or survivorship care plan. METHODS: A systematic review of eligible manuscripts was conducted using preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Relevant studies were identified via PubMed, CINAHL Plus, and the Cochrane Library from 2005 through 2013. Eligible studies were critically appraised with qualitative and quantitative appraisal tools. RESULTS: There were 29 studies included in this review; 19 were quantitative. Survivors and primary care physicians preferred a printable format delivered 0 to 6 months posttreatment and highlighting signs and symptoms of recurrence, late, and long-term effects, and recommendations for healthy living. Oncology providers supported the concept of treatment summary and survivorship care plan but reported significant barriers to their provision. No studies incorporated caregiver perspectives of treatment summary and survivorship care plan. CONCLUSION: This systematic review did not reveal conclusive evidence regarding the needs of survivors or providers regarding treatment summaries and survivorship care plans. A lack of rigorous studies contributed to this. IMPLICATIONS FOR CANCER SURVIVORS: Treatment summaries and survivorship care plans are useful for cancer survivors; however, future rigorous studies should be conducted to identify and prioritize the preferences of survivors regarding these.
Entities:
Keywords:
Cancer survivors; JBI-QARI; QAQTS; Survivorship care plans; Systematic review; Treatment summaries
Authors: Mary Ann Burg; Ellen D S Lopez; Amy Dailey; Mary Elspeth Keller; Brendan Prendergast Journal: J Gen Intern Med Date: 2009-11 Impact factor: 5.128
Authors: Steven C Palmer; Linda A Jacobs; Angela DeMichele; Betsy Risendal; Alison F Jones; Carrie Tompkins Stricker Journal: Support Care Cancer Date: 2014-01-12 Impact factor: 3.603
Authors: Christine E Hill-Kayser; Carolyn C Vachani; Margaret K Hampshire; Gloria Di Lullo; Linda A Jacobs; James M Metz Journal: Cancer Date: 2013-08-06 Impact factor: 6.860
Authors: Ann H Partridge; Virginia W Norris; Victoria S Blinder; Bruce A Cutter; Michael T Halpern; Jennifer Malin; Michael N Neuss; Antonio C Wolff Journal: Cancer Date: 2012-11-29 Impact factor: 6.860
Authors: Jackelyn B Payne; Kaylin V Dance; Monique Farone; Anh Phan; Cathy D Ho; Meghan Gutierrez; Lillian Chen; Christopher R Flowers Journal: Cancer Date: 2019-07-29 Impact factor: 6.860
Authors: Heather Greenlee; Christine L Sardo Molmenti; Katherine D Crew; Danielle Awad; Kevin Kalinsky; Lois Brafman; Deborah Fuentes; Zaixing Shi; Wei-Yann Tsai; Alfred I Neugut; Dawn L Hershman Journal: J Cancer Surviv Date: 2016-04-21 Impact factor: 4.442
Authors: Kristine K Browning; Alai Tan; Rupa Ghosh-Berkebile; Denise Schimming; Rachee Hatfield; Patrick DiMeo; Maryam B Lustberg; Dori L Klemanski Journal: J Cancer Surviv Date: 2019-08-31 Impact factor: 4.442
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Melanie R Keats; Kelsey Shea; Louise Parker; Samuel A Stewart; Annette Flanders; Mark Bernstein Journal: J Cancer Educ Date: 2019-08 Impact factor: 2.037
Authors: Paul B Jacobsen; Antonio P DeRosa; Tara O Henderson; Deborah K Mayer; Chaya S Moskowitz; Electra D Paskett; Julia H Rowland Journal: J Clin Oncol Date: 2018-05-18 Impact factor: 44.544